Topic review: Surface modifications enhancing biological activity of Guglielmi detachable coils in treating intracranial aneurysms

被引:29
作者
Abrahams, JM
Diamond, SL
Hurst, RW
Zager, EL
Grady, MS
机构
[1] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA
来源
SURGICAL NEUROLOGY | 2000年 / 54卷 / 01期
关键词
Aneurysm; biologically active devices; coil embolization; coil modification; endovascular therapy; Guglielmi detachable coils;
D O I
10.1016/S0090-3019(00)00269-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND Endovascular therapy with Guglielmi detachable coils is an accepted treatment option for patients with intracranial aneurysms. However, an emerging technology in the realm of endovascular tools is the use of traditional Guglielmi detachable coils with biologically active substances complexed to the coil surface to enhance aneurysm occlusion. METHODS We review the literature and current trends in modified Guglielmi detachable coils. Surface modifications with extracellular matrix proteins, growth factors, ion impregnation, and genetically altered cells have been used in animal studies to improve the cellular response of Guglielmi detachable coils. Similarly, coronary artery stents have been modified in several different ways to maintain vessel patency, contrary to the goal of endovascular therapy. We comparatively reviewed this literature to add insight into the evolution of the research on modified Guglielmi detachable coils. CONCLUSIONS Guglielmi detachable coil modifications have the potential to enhance aneurysm obliteration with directed cellular responses. This may allow aneurysm occlusion with coils in less time than untreated coils, thus decreasing the risks of aneurysm enlargement and hemorrhage. (C) 2000 by Elsevier Science Inc.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 51 条
  • [22] EFFICIENT AND SELECTIVE ADENOVIRUS-MEDIATED GENE-TRANSFER INTO VASCULAR NEOINTIMA
    GUZMAN, PJ
    LEMARCHAND, P
    CRYSTAL, RG
    EPSTEIN, SE
    FINKEL, T
    [J]. CIRCULATION, 1993, 88 (06) : 2838 - 2848
  • [23] Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries
    Hardhammar, PA
    vanBeusekom, HMM
    Emanuelsson, HU
    Hofma, SH
    Albertsson, PA
    Verdouw, PD
    Boersma, E
    Serruys, PW
    vanderGiessen, WJ
    [J]. CIRCULATION, 1996, 93 (03) : 423 - 430
  • [24] Antithrombogenic coating of stents using a biodegradable drug delivery technology
    Herrmann, R
    Schmidmaier, G
    Märkl, B
    Resch, A
    Hähnel, I
    Stemberger, A
    Alt, E
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 82 (01) : 51 - 57
  • [25] POLYMERIC STENTING IN THE PORCINE CORONARY-ARTERY MODEL - DIFFERENTIAL OUTCOME OF EXOGENOUS FIBRIN SLEEVES VERSUS POLYURETHANE-COATED STENTS
    HOLMES, DR
    CAMRUD, AR
    JORGENSON, MA
    EDWARDS, WD
    SCHWARTZ, RS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (02) : 525 - 531
  • [26] Horowitz M, 1997, AM J NEURORADIOL, V18, P510
  • [27] Horowitz MB, 1997, AM J NEURORADIOL, V18, P688
  • [28] In vitro proliferation and adhesion of basic fibroblast growth factor-producing fibroblasts on platinum coils
    Kallmes, DF
    Borland, MK
    Cloft, HJ
    Altes, TA
    Dion, JE
    Jensen, ME
    Hankins, GR
    Helm, GA
    [J]. RADIOLOGY, 1998, 206 (01) : 237 - 243
  • [29] Platinum coil-mediated implantation of growth factor-secreting endovascular tissue grafts: An in vivo study
    Kallmes, DF
    Williams, D
    Cloft, HJ
    Lopes, MBS
    Hankins, GR
    Helm, GA
    [J]. RADIOLOGY, 1998, 207 (02) : 519 - 523
  • [30] Kuiper KKJ, 1997, CIRCULATION, V96, P1607